Dr. Anthony P. Heaney, MD

Dr. Heaney practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Heaney's NPI, 1720016850, was assigned on June 29, 2006. Dr. Heaney graduated from Queen's University of Belfast COM in 1987. Dr. Heaney holds California license A92084.

Dr. Heaney's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Heaney's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Heaney is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Heaney to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Heaney practices, 3 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Heaney's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Heaney is licensed in California.

Dmand AI lists testicular dysfunction and underactive thyroid among the conditions Dr. Heaney treats.

CMS data shows 196 Medicare services from Dr. Heaney across 5 procedure codes in 2024, for 120 Medicare patients. Medicare paid $16,583 for them.

CMS counts 120 Medicare patients who saw Dr. Heaney in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 28% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Heaney's median patient age at 52, with 57% women.

In 2024, Dr. Heaney wrote 746 Medicare Part D claims for 88 patients. 55% of them were for generic drugs. CMS names the drug for 653 of them, across 16 drugs with 11 or more claims each, at $1,569,730 in total drug cost. In 2023, CMS named 676 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Heaney for performance year 2024, reported as part of a group. Dr. Heaney accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Heaney as offering telehealth.

Dmand AI links 32 papers to Dr. Heaney, published from 2008 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Neuroendocrine Tumors and Pituitary Neoplasms. Dr. Heaney's most frequent co-authors are Marvin Bergsneider, MD, Marilene Beth Wang, MD and Maria Fleseriu, MD.

Dmand AI links Dr. Heaney to 8 clinical trials, 5 of them phase 3 studies. Conditions studied include Pituitary ACTH Hypersecretion, Hyperpituitarism and Adrenocortical Hyperfunction. Novartis Pharmaceuticals sponsors the most, 4.

CMS Open Payments shows 572 general payments to Dr. Heaney from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Corcept Therapeutics paid the most, $192,780. It also lists 11 research payments totaling $46,379 from 2017 to 2022.

Dmand AI lists 12 awards for Dr. Heaney, most recently CMS Stage 1 EHR in 2013.

Dr. Heaney graduated from Queen's University of Belfast COM in 1987. Dr. Heaney is a member of ENDO.

Dr. Heaney is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.